ライト・ストラテジー
Lite Strategy, Inc.
Lite Strategy, Inc. functions as a clinical-stage pharmaceutical firm, concentrating its efforts on creating innovative and distinct therapeutic solutions for cancer patients. This entity, which was previously known as MEI Pharma, Inc., officially changed its designation to Lite Strategy, Inc. in September 2025. The company was established in 2000 and has its principal operations located in San Diego, California.
| Period | EPS | Revenue | FCF |
|---|---|---|---|
| 2026 Q4 | -0.38 | $0 | -$1M |
| 2026 Q3 | -3.56 | $0 | -$2M |
| 2025 Q2 | -4.62 | $0 | -$2M |
| 2025 Q1 | -0.55 | $0 | -$5M |
| 2025 Q4 | -0.40 | $0 | -$2M |
| 2025 Q3 | -0.39 | $0 | -$3M |
| 2024 Q2 |
| -0.40 |
| $0 |
| — |
| 2024 Q1 | -1.20 | $0 | -$11M |